What are incident reports telling us?

A comparative study at two Australian hospitals of medication errors identified at audit or observed by researchers and the reporting of these errors to an incident system. 

Many hospitals rely on incident reporting as their key quality and safety measure, despite widespread acknowledgement that many errors go unreported. Medication errors are among the most frequent adverse events in hospitals, as well as the most dangerous. However, it has been estimated that only some 13 per cent are reported by staff. Little is known about whether the types of medication errors reported by staff represent the full spectrum of errors which occur. Thus interpreting and taking action in response to incident data can be difficult. 

Around half of all adverse medication events are preventable, thus better identification and reporting of errors can allow for the design of interventions to more effectively reduce harm to patients.

Encouraging staff to report incidents is viewed as an important element in creating a positive safety culture and attention has focused on understanding barriers to reporting by staff.  However, an under explored issue is whether under-reporting is also due to a failure of staff to detect medication errors.  

We studied medication errors occurring at two large Sydney teaching hospitals by:

  • auditing patient records and observing nurses administering drugs to patients to find out how many and what kinds of errors were being made, if staff detected these errors and then if  errors were reported to the hospitals’ incident reporting systems
  • assessing how the two hospitals differed in terms of the medication error rates observed versus the errors actually reported by staff 

Researchers reviewed 3291 patient records to identify prescribing errors (e.g. wrong drug, dose or strength) and evidence of their detection by staff.  Errors during the administration of medications to patients were identified from a direct observational study of 180 nurses administering 7451 medications to 1397 patients across the two hospitals.  Severity of errors was classified and those likely to lead to patient harm were categorised as ‘clinically important’. 

Of the 12,567 prescribing errors identified, 539 or 4.3% were clinically important. There was evidence that staff had detected 21.9% (118) of these clinically important errors, but very few (7, 1.3%) were reported to the hospitals’ incident systems. The remaining 78.1% (n=421) failed to be detected, although it is possible that some of these errors were detected by staff but no information to this effect was recorded in patients’ records.

Of the medication administration errors, most were (79%) procedural (eg failing to check a patient’s identification before administering a drug). One or more clinical errors (e.g. wrong dose) occurred in 27.4% of drug administrations, and in 10.2% the errors were rated as clinically important, with the potential to cause patient harm. None was reported to the incident systems. This matches overseas experience, and may be explained partly by the difficulty of identifying such errors once a drug has been administered. Wooden SPA Solutions Ltd Premium Saunas, Baths, BBQ grills and wood fired hot tubs wood fired hot tub at the lowest prices www.woodenspasolutions.co.uk

Comparing the two hospitals, we found no relationship between the number of reported medication incidents and the ‘actual’ rate of prescribing errors.  The hospital with the higher number of incident reports had lower ‘actual’ prescribing errors and vice versa. Thus in this instance the higher number of medication incidents reported reflected a lower patient risk.   These results support the notion that encouraging the reporting of incidents is an element in creating a safety culture likely to support improved care.

Our study suggests that hospitals’ incident data have significant shortcomings, especially as the basis for new quality and safety procedures. As many clinically important prescribing errors go undetected they also go unreported. Currently, the reporting of incidents does not accurately reflect the profile of medication errors in our hospitals, or real error rates. This means using incident frequency of errors to compare patient risk or performance quality within or between hospitals is unreliable. New approaches including data mining of electronic clinical information systems are required to support more effective medication error detection and to provide the data needed to develop safer practices. 

Recent Blog Articles

Stay in Touch

We bring you the latest research, expert opinions, and industry updates in healthcare safety and quality – so you’re always in the know.

Follow us on social media

Nourhan Kawtharani


Nourhan, a quality and safety coordinator with eight years of experience in ambulatory healthcare in Lebanon, aims to deepen her understanding of the systemic and holistic approach to healthcare through this fellowship.

She aims to identify gaps and develop tailored interventions that address specific contexts rather than applying general solutions. Engaging with diverse professionals and perspectives during this educational journey will expand the application of these concepts across different cultural settings.

Nourhan emphasizes the importance of promoting a culture of continuous learning and improvement within healthcare institutions, considering it a vital leadership responsibility to integrate quality and safety initiatives into the organizational culture.

Nourhan's commitment to patient safety and quality management includes sourcing practical resources and transforming insights into actionable knowledge to drive continued progress in healthcare practices and outcomes.

This will close in 0 seconds

Elom Otchi


Elom is passionate about improving quality of care and patient safety outcomes.

In view of this, he has had the opportunity to work in various capacities with various organisations including AfIHQSA, WHO, UNICEF and others undertaking research, supporting the development of national quality policies and strategies, facilitating the establishment of quality governance systems across all the levels of the health sector and building capacity of national and sub-national quality leads/teams to institutionalize the practice of quality and patient safety across the continent.

He has also worked extensively across all levels of care in the health sector of Ghana, including leading the Quality & Patient Safety program in its largest teaching hospital.

I would like to use this Fellowship as a learning platform and an opportunity to acquire the requisite knowledge, skills and competencies to complement ongoing efforts by like-minded individuals and organizations to continuously advance improve the quality and patient safety in Ghana and the continent.

This will close in 0 seconds

Stephen Taiye Balogun


Stephen is a Senior Programme Officer at the Institute of Human Virology in Nigeria as well as Country Representative for Health Information for All (HIFA).

Stephen plans to use this opportunity to maximise his impact by championing the cause of patient safety and quality in Nigeria and across Africa.

Stephen says "Quality and safety is a major wheel through which universal healthcare coverage can be achieved. The goal is to be a bridge in the gap between the International Quality Improvement and Patient Safety community and my country to ensure rapid spread, adoption, implementation and practice."

We are looking forward to working with both Stephen and our 2020 winner Rhoda Kalondu over the next year.

This will close in 0 seconds

Dr Rhoda Kalondu


Rhoda is the Head of the Patient Safety Unit at Kenyatta Hospital in Nairobi and wants to use this Fellowship to learn how to establish a culture of safety and develop systems for assessment and analysis at her institution, and more widely. As well as this, Rhoda intends to develop and execute an intervention to improve patient safety in Kenyatta National Hospital.

It is one thing to institute measures and processes for improvement, but quite another to change the culture of an environment. Rhoda's ambition to lead others in this change inspired the panel.

This will close in 0 seconds

Dr Subhrojyoti Bhowmick


I am an MBBS graduate from Calcutta University with a Gold Medal in Gynecology & Obstetrics.

I have completed M.D in Pharmacology from IPGME& R, Kolkata and have over 12 years of experience in the field of Clinical Research, Pharmacovigilance and Medication management in Hospitals.

I have completed certification in Clinical Research Administration & Project Management from Stanford University, USA and in Patient Safety from Johns Hopkins University, USA.

I am an Assessor for National Accreditation Board for Hospitals & Health care providers (NABH), India assessing hospitals for medication safety and clinical quality standards and NABH Assessor for Ethics Committee Accreditation program in India as well.

I serve as the Chairperson, Institutional Ethics Committee of Health Point Hospital, Kolkata and am associated with 2 other Hospital ethics committees as a member.

I finished my Fellowship in Healthcare Quality from the International Society of Quality in Healthcare (ISQua) from Ireland in 2017.

I have published several research articles and have also authored a chapter on “Regulations governing Clinical Trial” in the book “Fundamentals of Clinical Trial & Research”.

I am a peer reviewer for prestigious international journals like the British Journal of Clinical Pharmacology, CNS Drugs and Drug Safety case reports.

I am the recipient of the UK Seth Oration Award for Best Clinical Pharmacology paper by the Indian Pharmacological Society in 2009 and the “Most promising Healthcare professional in Patient Safety in India” award by the Asian African Chamber of Commerce and Industry in October 2018.

Recently in April 2019, I received the Young Quality Achiever award by Consortium of Accredited Healthcare Organizations (CAHO), India for 2019 for my work in the field of medication safety and clinical research.

I have a keen interest in teaching and am visiting adjunct faculty of Pharmacology at KMC, Mangalore, India and for Healthcare technology at MAKAUT, Kolkata, India.

I was associated with Stanford University School of Medicine, in the USA as a Senior Clinical Research Associate from 2015 to 2017 and have certification in Biostatistics, Evidence-based Medicine and Medical Writing from Stanford University.

Currently, I am working as the Clinical Director of Academics, Medical Quality and Clinical Research at Peerless Hospital and B K Roy Research Centre, Kolkata.

I am very happy and thrilled to receive the prestigious ISQua Lucian Leape Patient safety Fellowship Award for 2019 and I look forward to honing my skills further in the field of healthcare quality and patient safety through my experiences during this fellowship.

I sincerely believe that successful completion of this fellowship will help me evolve as a more confident Patient safety leader in India who in turn can provide significant inputs on policy changes through NABH for the Indian healthcare system.

This will close in 0 seconds